Statins Could Fight Alzheimer's in T2D Patients
the MPR take:
For patients with type 2 diabetes, statin therapy may decrease the risk of developing Alzheimer's disease, but not non-Alzheimer dementia. The study, published in the journal PLOS One, evaluated data from the National Health Insurance Research Database in Taiwan. Patients with type 2 diabetes with regular statin use were followed up for up to eight years. Regular statin use in these patients was linked to a decreased risk of developing Alzheimer's disease dementia, but not non-Alzheimer's dementia. Both types of statins atorvastatin and simvastatin were shown to have positive effects.
READ FULL ARTICLE From Forbes